Quest Diagnostics Incorporated (DGX)
Processes blood tests and medical lab work for doctors, hospitals, and patients nationwide
$231.84+0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+35.7%
The outlook
DGX is trading near the top of its 52-week range and well above both its 50- and 200-day moving averages, showing sustained upward momentum. Analysts lean bullish with a "Buy" consensus, though the average price target sits roughly 3% above the current price. The stock's trailing P/E of 24.2 reflects a premium valuation relative to recent historical levels.
What’s behind the score
Analyst consensusBuy — 2.1 avg of 16 analysts
Price trendAbove its 50- & 200-day averages
52-week range92% of the way from its 52-week low to high
Price targetAvg target +3% vs current price
Analyst price target
~12-month · 16 analysts$239.38average target+3.3% vs now
Now $231.84
Low $204.00High $265.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$25.59B
52-wk high
$237.78
52-wk low
$165.78
50-day avg
$203.25
200-day avg
$193.00
Trailing P/E
24.2